We would like to thank Dr Spartalis et al for their interest in our article [1]. It has been shown that human immunodeficiency virus and hepatitis C virus (HIV-HCV) coinfection is associated with shorter survival in patients with hepatocellular carcinoma (HCC) [2]. In addition, the presence of hepatitis B or C is associated with an increased risk of HCC in HIV patients [3]. We thus agree that HIV-HCV coinfection is associated with a worse prognosis in patients with HCC. However, since our cohort did not include any patients with HIV infection we were not able to study this group.
Biography
University of New Mexico, New Mexico, USA
Footnotes
Conflict of Interest: None
References
- 1.Alkhalili E, Greenbaum A, Luo L, et al. Viral hepatitis status does not affect survival in patients with hepatocellular carcinoma. Ann Gastroenterol. 2017;30:101–105. doi: 10.20524/aog.2016.0097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lewin M, Gelu-Simeon M, Ostos M, et al. Imaging features and prognosis of hepatocellular carcinoma in patients with cirrhosis who are coinfected with human immunodeficiency virus and hepatitis C virus. Radiology. 2015;277:443–453. doi: 10.1148/radiol.2015141500. [DOI] [PubMed] [Google Scholar]
- 3.Ioannou GN, Bryson CL, Weiss NS, Miller R, Scott JD, Boyko EJ. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology. 2013;57:249–257. doi: 10.1002/hep.25800. [DOI] [PubMed] [Google Scholar]